# Dual mechanism of anti-seizure medications in controlling seizure activity

**Authors:** Guillermo M Besné, Emmanuel Molefi, Billy Smith, Nathan Evans, Sarah J Gascoigne, Chris Thornton, Fahmida A Chowdhury, Beate Diehl, John S Duncan, Andrew W McEvoy, Anna Miserocchi, Jane de Tisi, Matthew C Walker, Peter N Taylor, Yujiang Wang

PMC · DOI: 10.1093/braincomms/fcag088 · Brain Communications · 2026-03-16

## TL;DR

This study shows that anti-seizure medications control seizures through two mechanisms: suppressing specific seizure patterns and shortening the duration of others.

## Contribution

The paper identifies two distinct mechanisms by which ASMs modulate seizure activity using iEEG data from ASM tapering.

## Key findings

- ASM tapering unmasked new seizure propagation patterns in 40% of patients, leading to longer seizures.
- Lower ASM levels prolonged existing seizure patterns by 12–224% depending on dosage and tapering.
- ASMs both suppress specific seizure states and curtail the duration of other seizure patterns.

## Abstract

Anti-seizure medications (ASMs) can reduce seizure duration, but their precise modes of action are unclear. Specifically, it is unknown whether ASMs shorten seizures by curtailing existing seizure activity early or by selectively suppressing certain seizure activity patterns from emerging. We retrospectively analysed intracranial EEG (iEEG) recordings of 457 seizures from 28 people with epilepsy undergoing ASM tapering. Beyond measuring seizure occurrence and duration, we categorized distinct seizure propagation activity patterns (states) based on spatial and frequency power characteristics and related these to different ASM levels. We found that reducing ASM levels led to increased seizure frequency (r = 0.87, P < 0.001) and longer seizure duration (β = −0.033, P < 0.001), consistent with prior research. Further analysis revealed two distinct mechanisms in which seizures became prolonged: Emergence of new seizure propagation patterns—In ∼40% of patients, ASM tapering unmasked additional seizure activity states, and seizures containing these ‘taper-emergent states’ were substantially longer (r = 0.49, P < 0.001). Prolongation of existing seizure patterns—Even in seizures without taper-emergent states, lower ASM levels still resulted in ∼12–224% longer durations depending on the ASM dosage and tapering (β = −0.049, P < 0.001). ASMs influence seizures through two mechanisms: they (i) suppress specific seizure propagation patterns (states) in an all-or-nothing fashion and (ii) curtail the duration of other seizure patterns. These findings highlight the complex role of ASMs in seizure modulation and could inform personalized dosing strategies for epilepsy management. These findings may also have implications in understanding the effects of ASMs on cognition and mood.

Anti-seizure medications (ASMs) are known to reduce seizure duration, but there appears to be a dual mechanism through which this is achieved. First, ASMs suppress specific seizure activity and propagation patterns in an all-or-nothing fashion depending on dosage and (ii) curtail the duration of other seizure patterns.

Graphical Abstract

## Linked entities

- **Diseases:** epilepsy (MONDO:0005027)

## Full-text entities

- **Genes:** H19 (H19 imprinted maternally expressed transcript) [NCBI Gene 283120] {aka ASM, ASM1, BWS, D11S813E, GMRSP, LINC00008}
- **Diseases:** seizure (MESH:D012640), epilepsy (MESH:D004827)
- **Chemicals:** ASMs (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13023363/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13023363/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC13023363/full.md

---
Source: https://tomesphere.com/paper/PMC13023363